Physician

Aarti Manchanda, MD

According to 2025 Medicare claims, Aarti Manchanda, MD (NPI: 1669788709) practices endocrinology in the Chicago-Naperville-Schaumburg, IL market, with the plurality of this provider's patient population coming from Du Page, IL. This provider's primary affiliated billing organization is ENDEAVOR HEALTH MEDICAL GROUP (NPI: 1497701882; TIN: 363738206) and primary practice location at 60126-5659.

Manchanda's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 447 traditional Medicare patients, billed 11,021 HCPCS/CPT codes, and received $224,804 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 4,240 prescription claims across 597 beneficiaries totaling $2,736,368 in drug costs, led by Trulicity (Dulaglutide). DME data shows 409 claims. Open Payments data shows 1 records totaling $29. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $6,358 to $224,804. Similarly, Part D prescription costs have risen steadily, from $9,430 to $2,736,368. For DME billing, reported payments moved sharply higher in recent years, from $1,221 to $111,340.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	43	88	$6,358
2016	161	520	$32,261
2017	253	675	$40,775
2018	346	1,045	$48,385
2019	453	9,376	$126,442
2020	465	11,550	$154,839
2021	466	12,797	$219,094
2022	468	14,011	$225,681
2023	472	11,382	$218,704
2024	447	11,021	$224,804

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	24	62	$9,430
2016	115	826	$219,032
2017	187	1,457	$648,541
2018	255	1,883	$1,010,103
2019	341	2,284	$1,321,001
2020	411	2,803	$1,895,481
2021	454	3,145	$2,390,303
2022	493	3,257	$2,481,254
2023	550	3,799	$3,068,003
2024	597	4,240	$2,736,368

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	40	71	$1,184
2017	65	135	$2,420
2018	105	237	$9,132
2019	160	388	$38,869
2020	136	424	$40,268
2021	146	461	$51,947
2022	129	464	$60,675
2023	137	524	$72,339
2024	163	409	$111,009

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	195	351	$100
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	239	328	$71
95251	Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report	59	105	$29
83036	Hemoglobin a1c level	181	360	$10
82947	Blood glucose (sugar) level	173	340	$4

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Trulicity	Dulaglutide	387	19,314	$647,400
Ozempic	Semaglutide	331	18,891	$601,166
Korlym	Mifepristone	11	330	$476,609
Jardiance	Empagliflozin	99	7,334	$139,841
Humulin R U-500 Kwikpen	Insulin Regular, Human	42	2,353	$128,938

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	57	229	$105,021
E2103	Non-adjunctive, non-implanted continuous glucose monitor or receiver	N	17	17	$3,646
A4253	Blood glucose test or reagent strips for home blood glucose monitor, per 50 strips	N	56	110	$2,253
A4259	Lancets, per box of 100	N	33	53	$89

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	1	$29	Dexcom, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Aarti Manchanda, MD?

Tedicare shows public-source Medicare data for Aarti Manchanda, MD (NPI 1669788709), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Aarti Manchanda, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Aarti Manchanda, MD?

Aarti Manchanda, MD is linked to ENDEAVOR HEALTH MEDICAL GROUP (billing NPI 1497701882) in the available physician profile data.

Does Aarti Manchanda, MD have Open Payments data?

Aarti Manchanda, MD has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.